MedPath

DIPAN SHAH

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

DeBakey Cardiovascular Magnetic Resonance Study

Recruiting
Conditions
Cardiovascular Diseases
Interventions
Diagnostic Test: Cardiovascular Magnetic Resonance
First Posted Date
2020-02-24
Last Posted Date
2020-02-24
Lead Sponsor
Dipan Shah
Target Recruit Count
100000
Registration Number
NCT04281823
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance

Not Applicable
Conditions
Coronary Artery Disease
Cardiomyopathy
Interventions
Drug: Cardiac MRI taken using contrast agent, Dotarem® (Gd-DOTA)
Drug: Cardiac MRI with contrast agent, Gadovist
First Posted Date
2017-02-20
Last Posted Date
2019-01-22
Lead Sponsor
Dipan Shah
Target Recruit Count
120
Registration Number
NCT03057561

Effect of MitraClip on Acute and Chronic Reverse Cardiac Remodeling Assessed by CMR: The MITRA-REVERSE Study

Conditions
Mitral Regurgitation
Interventions
Diagnostic Test: Cardiac MRI with or without contrast dye
Diagnostic Test: Blood sample
First Posted Date
2016-10-05
Last Posted Date
2019-08-15
Lead Sponsor
Dipan Shah
Target Recruit Count
60
Registration Number
NCT02924363
Locations
🇺🇸

Houston Methodist Hospital, Houston, Texas, United States

🇺🇸

Piedmont Heart Institute, Atlanta, Georgia, United States

Diagnostic Study of Rapid Regadenoson Stress Cardiovascular Magnetic Resonance (CMR) to Detect Coronary Artery Disease

Phase 4
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2011-10-04
Last Posted Date
2017-10-03
Lead Sponsor
Dipan Shah
Target Recruit Count
50
Registration Number
NCT01446094
Locations
🇺🇸

The Methodist Hospital, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath